![Sarah DeFeo](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Sarah DeFeo
Direttore Tecnico/Scientifico/R&S presso Ovarian Cancer Research Fund, Inc.
Profilo
Sarah DeFeo is currently the Vice President-Scientific Affairs & Programs at Ovarian Cancer Research Fund, Inc. She previously worked as a Principal at Icahn School of Medicine at Mount Sinai.
Ms. DeFeo holds a graduate degree from The Trustees of Columbia University in The City of New York and an undergraduate degree from Vassar College.
Posizioni attive di Sarah DeFeo
Società | Posizione | Inizio |
---|---|---|
Ovarian Cancer Research Fund, Inc.
![]() Ovarian Cancer Research Fund, Inc. Investment ManagersFinance Ovarian Cancer Research Fund, Inc. offers funds to find a method of early detection and ultimately a cure for ovarian cancer. It provides education and support to families living through an ovarian cancer diagnosis, OCRF funds the research and programs needed to ensure hope for a future without ovarian cancer. The company was founded by Ann Schreiber in 1994 and is headquartered in New York, NY. | Direttore Tecnico/Scientifico/R&S | 10/08/2010 |
Precedenti posizioni note di Sarah DeFeo
Società | Posizione | Fine |
---|---|---|
Icahn School of Medicine at Mount Sinai | Corporate Officer/Principal | - |
Formazione di Sarah DeFeo
Vassar College | Undergraduate Degree |
The Trustees of Columbia University in The City of New York | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
Ovarian Cancer Research Fund, Inc.
![]() Ovarian Cancer Research Fund, Inc. Investment ManagersFinance Ovarian Cancer Research Fund, Inc. offers funds to find a method of early detection and ultimately a cure for ovarian cancer. It provides education and support to families living through an ovarian cancer diagnosis, OCRF funds the research and programs needed to ensure hope for a future without ovarian cancer. The company was founded by Ann Schreiber in 1994 and is headquartered in New York, NY. | Finance |
- Borsa valori
- Insiders
- Sarah DeFeo